Pharmaceutical Dosage Forms - Parenteral Medications: Volume 3: Regulations, Validation and the Future
Editat de Sandeep Nema, John D. Ludwigen Limba Engleză Hardback – 26 aug 2010
First published in 1984 (as two volumes) and then last revised in 1993 (when it grew to three volumes), this latest revision will address the plethora of changes in the science and considerable advances in the technology associated with these products and routes of administration. The third edition of this book maintains the features that made the last edition so popular but comprises several brand new chapters, revisions to all other chapters, as well as high quality illustrations.
Volume three presents:
• An in-depth discussion of regulatory requirements, quality assurance, risk assessment and mitigation, and extractables/leachables.
• Specific chapters on parenteral administrations devices, injection site pain assessment, and parenteral product specifications and stability testing.
• Forward-thinking discussions on the future of parenteral product manufacturing, and siRNA delivery systems.
• New chapters covering recent developments in the areas of visual inspection, quality by design (QbD), process analytical technology (PAT) and rapid microbiological methods (RMM ), and validation of drug product manufacturing process.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 313.71 lei 6-8 săpt. | |
CRC Press – 14 oct 2024 | 313.71 lei 6-8 săpt. | |
Hardback (2) | 931.91 lei 6-8 săpt. | |
CRC Press – 26 aug 2010 | 931.91 lei 6-8 săpt. | |
CRC Press – 26 aug 2010 | 1017.80 lei 6-8 săpt. |
Preț: 931.91 lei
Preț vechi: 1257.05 lei
-26% Nou
Puncte Express: 1398
Preț estimativ în valută:
178.37€ • 185.90$ • 148.48£
178.37€ • 185.90$ • 148.48£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781420086478
ISBN-10: 1420086472
Pagini: 326
Ilustrații: 90 b/w images
Dimensiuni: 178 x 254 x 24 mm
Greutate: 0.79 kg
Ediția:Revizuită
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
ISBN-10: 1420086472
Pagini: 326
Ilustrații: 90 b/w images
Dimensiuni: 178 x 254 x 24 mm
Greutate: 0.79 kg
Ediția:Revizuită
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
Public țintă
AcademicNotă biografică
Sandeep Nema Ph.D. is Executive Director, Pharmaceutical R&D, BioTherapeutics Pharmaceutical Sciences at Pfizer in St. Louis. Since graduating in 1992 with his doctorate, Dr. Nema has been involved with the development of small molecule and protein drugs via parenteral delivery, first at Mallinckrodt Medical and then at Pfizer (Searle, Pharmacia), and has led the formulation of four launched products. He is active in the American Association of Pharmaceutical Scientists (AAPS) and the Parenteral Drug Association (PDA), where he has chaired several meetings and focus groups. Dr. Nema holds an adjunct faculty appointment at the University of Tennessee.
John D. Ludwig Ph.D. is Vice President, Business Strategy, Operations, and Clinical Supply Planning, BioTherapeutics Pharmaceutical Sciences at Pfizer, and Site Director for the company’s St. Louis Laboratories. Dr. Ludwig received a B.S. degree in Pharmacy and Ph.D. degree in Pharmaceutics from the University of Tennessee, Memphis and has held numerous research and development positions at Burroughs Wellcome Co, Searle, Inc., Pharmacia, Inc., and Pfizer. He is active in the American Association of Pharmaceutical Scientists (AAPS) and the Parenteral Drug Association (PDA) Training and Research Institute, where he has contributed to developing professional training courses and has regularly served as an instructor.
John D. Ludwig Ph.D. is Vice President, Business Strategy, Operations, and Clinical Supply Planning, BioTherapeutics Pharmaceutical Sciences at Pfizer, and Site Director for the company’s St. Louis Laboratories. Dr. Ludwig received a B.S. degree in Pharmacy and Ph.D. degree in Pharmaceutics from the University of Tennessee, Memphis and has held numerous research and development positions at Burroughs Wellcome Co, Searle, Inc., Pharmacia, Inc., and Pfizer. He is active in the American Association of Pharmaceutical Scientists (AAPS) and the Parenteral Drug Association (PDA) Training and Research Institute, where he has contributed to developing professional training courses and has regularly served as an instructor.
Cuprins
Volume 3: CGMP Regulations of Parenteral Drugs L Terry E. Munson Risk Assessment and Mitigation in Aseptic Processing L James Agalloco and James Akers Validation of Drug Product Manufacturing Processes: NCEs and NBEs L Karoline Bechtold-Peters Visual Inspection L Maria Toler and Sandeep Nema Advances in Parenteral Injection Devices and Aids L Donna L. French and James J. Collins, Jr. SiRNA Targeting Using Injectable Nano-based Delivery Systems L Lan Feng and Russell J. Mumper Excipients for Parenteral Dosage Forms: Regulatory Considerations and Controls L Sandeep Nema Techniques to Evaluate Damage and Pain on Injection L Gayle A. Brazeau, Jessica Klapa and Pramod Gupta Parenteral Product Specifications and Stability L Michael Bergren Extractables and Leachables L Edward Smith and Dianne M. Paskiet Process Analytical Technology and Rapid Microbial Methods L Geert Verdonk and Tony Cundell Quality Assurance Michael Gorman L Application of Quality by Design in CMC Development L Roger Nosal, Tom Garcia, Vince McCurdy, Amit Banerjee, Carol F. Kirchhoff, Satish K. Singh Future of Parenteral Manufacturing L James Agalloco, James Akers, and Russell Madsen
Descriere
Regulations, Validation and the Future is the third volume in the Pharmaceutical Dosage Forms — Parenteral Medications three-volume set. The book presents an in-depth discussion of regulatory requirements, quality assurance, risk assessment and mitigation, and extractables/leachables. It explores parenteral administrations devices, injection site pain assessment, parenteral product specifications, and stability testing. It also discusses and the future of parenteral product manufacturing and siRNA delivery systems. New chapters cover recent developments in the areas of visual inspection, quality by design (QbD), process analytical technology (PAT) and rapid microbiological methods (RMM ), as well as validation of drug product manufacturing process.